The purpose of this study is to evaluate the efficacy (assessed by clinical evaluation of eczema/atopic lesion severity \[atopic dermatitis severity index {ADSI} scoring\] and perceived benefits in itch \[visual analog score {VAS} scoring\]) and tolerability (assessed by clinical grading) of an investigational spot treatment Gel Cream when used on a target site of participants with mild to moderate atopic dermatitis.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Rajka and Langeland Severity Index Score of Target Lesion
Timeframe: At Screening
Atopic Dermatitis Severity Index (ADSI) Score of Target Lesion
Timeframe: Up to 14 days
Dryness of Target Lesion
Timeframe: Up to 14 days
Tactile Roughness of Target Lesion
Timeframe: Up to 14 days
Erythema of Target Lesion
Timeframe: Up to 14 days
Pruritus of Target Lesion
Timeframe: Up to 14 days
Skin Tone of Lesion Compared to Normal Overall Skin Tone
Timeframe: Up to 14 days
Overall Irritation of Facial Skin
Timeframe: Up to 14 days
Itch Assessment of Target Lesion
Timeframe: Up to 14 days
Soothing Assessments of Target Lesion
Timeframe: Up to 14 days
Cooling Assessment of Target Lesion
Timeframe: Baseline (Day 0)
Burning/Stinging Sensation of the Facial Skin
Timeframe: Up to 14 days
Skin pH Measurements of Target Lesion
Timeframe: Up to 14 days
Skin Hydration of Target Lesion as Measured by Corneometer
Timeframe: Up to 14 days
Transepidermal Water Loss (TEWL) Measurement of Target Lesion
Timeframe: Up to 14 days
Digital Photograph of Target Lesion
Timeframe: Up to 14 days
Microbiome Sampling of Target Lesion
Timeframe: Up to 14 days
Itch Quality of Life (ItchQOL) Questionnaire
Timeframe: Up to 14 days
Dermatology Life Quality Index (DLQI) Score
Timeframe: Up to 14 days
Final Assessment Questionnaire
Timeframe: At Day 14